atrial fibrillation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Younger than 75 years of age, more than 18 years of age; 2. persistent atrial fibrillation duration of more than 1 week; 3. long-lasting persistent atrial fibrillation, atrial fibrillation time more than 1 year; 4. left atrial diameter less than 60mm; 5. cardiac function NYHA-II level, and EF greater than 40% or more; 6. 1 month after stroke, muscle strength in patients with more than 4, and sanity clear; 7. The investigator agreed to participate in the clinical trial and sign informed consent, and agreed to follow the proof program requirements for follow-up evaluation.
Exclusion criteria
Exclusion criteria: 1. hyperthyroidism caused by atrial fibrillation, hyperthyroidism is not controlled before; 2. rheumatic valvular disease caused by atrial fibrillation; 3. atrial fibrillation caused by congenital heart disease; 4. pulmonary heart disease and pulmonary hypertension in patients with atrial fibrillation; 5. patients with cardiomyopathy complicated by atrial fibrillation; 6. have acute or severe systemic infection; 7. previous CABG (CABG) and valve replacement surgery and other thoracotomy; 8. have obvious bleeding tendency and blood system diseases; 9. aortic dissection or aortic aneurysm patients; 10. malignant tumors and end-stage disease patients; 11. patients with any other condition considered unsuitable to participate in the trial; 12. Researchers from the medical ethics point of view it is necessary to terminate the study of patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| DCG;echocardiography;Cardiac electrophysiological examination; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pulmonary vein CT;Blood biochemical examination;Esophageal ultrasound; | — |
Countries
China
Contacts
Shanghai Jiao Tong University Affiliated Shanghai Sixth People's Hospital